{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:11:08Z","timestamp":1782951068651,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Highly pathogenic avian influenza virus (HPAIV) is a serious threat not only to domestic fowls but also to humans. Vaccines inducing long-lasting immunity against HPAIV are required. In the present study, we generated recombinant measles virus (MV) expressing the hemagglutinin protein of HPAIV without the multibasic site necessary for its pathogenicity in chickens using the backbone of an MV vaccine strain (rMV-Ed-H5HA) or a wild-type MV-derived mutant (rMV-HL-Vko-H5HA). We examined protective efficacy of the candidate vaccines in the monkey infection model by the challenge with a HPAIV (H5N1). Cynomolgus monkeys inoculated with the candidate vaccines produced both anti-H5 HA and anti-MV antibodies. They recovered earlier from influenza symptoms than unvaccinated monkeys after the challenge with the HPAIV strain. Chest radiography and histopathological analyses confirmed less severe pneumonia in the vaccinated monkeys. Vaccination tended to suppress viral shedding and reduced the interleukin-6 levels in the lungs. Furthermore, the vaccination with rMV-Ed-H5HA of monkeys with pre-existing anti-MV immunity induced the production of anti-H5 HA antibodies. These results suggest that both candidate vaccines effectively reduce disease severity in na\u00efve hosts, and that rMV-Ed-H5HA is a particularly good candidate vaccine against HPAIV infection.<\/jats:p>","DOI":"10.1038\/s41598-017-08326-x","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T15:10:25Z","timestamp":1505401825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys"],"prefix":"10.1038","volume":"7","author":[{"given":"Tomoko","family":"Fujiyuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kuraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-jeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Munekata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusako","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Omi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shosaku","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"8326_CR1","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0140-6736(08)60627-3","volume":"371","author":"A Gambotto","year":"2008","unstructured":"Gambotto, A., Barratt-Boyes, S. M., de Jong, M. D., Neumann, G. & Kawaoka, Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet \n                           371, 1464\u20131475 (2008).","journal-title":"Lancet"},{"key":"8326_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000320299","volume":"19","author":"S Adams","year":"2010","unstructured":"Adams, S. & Sandrock, C. Avian influenza: update. Medical Principles and Practice \n                           19, 421\u2013432 (2010).","journal-title":"Medical Principles and Practice"},{"key":"8326_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virusres.2013.07.017","volume":"178","author":"M Imai","year":"2013","unstructured":"Imai, M. et al. Transmission of influenza A\/H5N1 viruses in mammals. Virus research \n                           178, 15\u201320 (2013).","journal-title":"Virus research"},{"key":"8326_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2014.02.040","volume":"157","author":"M Linster","year":"2014","unstructured":"Linster, M. et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A\/H5N1 virus. Cell \n                           157, 329\u2013339 (2014).","journal-title":"Cell"},{"key":"8326_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1586\/14760584.7.2.241","volume":"7","author":"HM El Sahly","year":"2008","unstructured":"El Sahly, H. M. & Keitel, W. A. Pandemic H5N1 influenza vaccine development: an update. Expert review of vaccines \n                           7, 241\u2013247 (2008).","journal-title":"Expert review of vaccines"},{"key":"8326_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3201\/eid1201.051147","volume":"12","author":"CJ Luke","year":"2006","unstructured":"Luke, C. J. & Subbarao, K. Vaccines for pandemic influenza. Emerging infectious diseases \n                           12, 66\u201372 (2006).","journal-title":"Emerging infectious diseases"},{"key":"8326_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cimid.2007.07.012","volume":"31","author":"S Brandler","year":"2008","unstructured":"Brandler, S. & Tangy, F. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Comparative immunology, microbiology and infectious diseases \n                           31, 271\u2013291 (2008).","journal-title":"Comparative immunology, microbiology and infectious diseases"},{"key":"8326_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4161\/hv.23220","volume":"9","author":"HY Naim","year":"2013","unstructured":"Naim, H. Y. Applications and challenges of multivalent recombinant vaccines. Human vaccines & immunotherapeutics \n                           9, 457\u2013461 (2013).","journal-title":"Human vaccines & immunotherapeutics"},{"key":"8326_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/hv.34298","volume":"11","author":"HY Naim","year":"2015","unstructured":"Naim, H. Y. Measles virus. Human vaccines & immunotherapeutics \n                           11, 21\u201326 (2015).","journal-title":"Human vaccines & immunotherapeutics"},{"key":"8326_CR10","first-page":"75","volume":"3","author":"H Sato","year":"2012","unstructured":"Sato, H., Yoneda, M., Honda, T. & Kai, C. Morbillivirus receptors and tropism: multiple pathways for infection. Frontiers in microbiology \n                           3, 75 (2012).","journal-title":"Frontiers in microbiology"},{"key":"8326_CR11","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.cimid.2010.02.006","volume":"33","author":"M Satoh","year":"2010","unstructured":"Satoh, M. et al. Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD\/Scid\/Jak3null mouse. Comparative immunology, microbiology and infectious diseases \n                           33, e81\u201388 (2010).","journal-title":"Comparative immunology, microbiology and infectious diseases"},{"key":"8326_CR12","doi-asserted-by":"publisher","first-page":"e58414","DOI":"10.1371\/journal.pone.0058414","volume":"8","author":"M Yoneda","year":"2013","unstructured":"Yoneda, M. et al. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One \n                           8, e58414 (2013).","journal-title":"PLoS One"},{"key":"8326_CR13","doi-asserted-by":"publisher","first-page":"e83551","DOI":"10.1371\/journal.pone.0083551","volume":"8","author":"T Fujiyuki","year":"2013","unstructured":"Fujiyuki, T. et al. Experimental infection of macaques with a wild water bird-derived highly pathogenic avian influenza virus (H5N1). PLoS One \n                           8, e83551 (2013).","journal-title":"PLoS One"},{"key":"8326_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.virol.2008.02.015","volume":"375","author":"H Sato","year":"2008","unstructured":"Sato, H. et al. Measles virus induces cell-type specific changes in gene expression. Virology \n                           375, 321\u2013330 (2008).","journal-title":"Virology"},{"key":"8326_CR15","doi-asserted-by":"publisher","first-page":"e38214","DOI":"10.1371\/journal.pone.0038214","volume":"7","author":"SG Paquette","year":"2012","unstructured":"Paquette, S. G. et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One \n                           7, e38214 (2012).","journal-title":"PLoS One"},{"key":"8326_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/314823","volume":"180","author":"DP Skoner","year":"1999","unstructured":"Skoner, D. P., Gentile, D. A., Patel, A. & Doyle, W. J. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. The Journal of infectious diseases \n                           180, 10\u201314 (1999).","journal-title":"The Journal of infectious diseases"},{"key":"8326_CR17","doi-asserted-by":"publisher","first-page":"e50144","DOI":"10.1371\/journal.pone.0050144","volume":"7","author":"Z Chen","year":"2012","unstructured":"Chen, Z. et al. Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5. PLoS One \n                           7, e50144 (2012).","journal-title":"PLoS One"},{"key":"8326_CR18","doi-asserted-by":"publisher","first-page":"37915","DOI":"10.1038\/srep37915","volume":"6","author":"F Yasui","year":"2016","unstructured":"Yasui, F. et al. Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus. Scientific reports \n                           6, 37915 (2016).","journal-title":"Scientific reports"},{"key":"8326_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vaccine.2015.11.045","volume":"34","author":"S Shi","year":"2016","unstructured":"Shi, S. et al. Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines. Vaccine \n                           34, 350\u2013357 (2016).","journal-title":"Vaccine"},{"key":"8326_CR20","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1128\/JVI.06930-11","volume":"86","author":"F Zhou","year":"2012","unstructured":"Zhou, F. et al. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. Journal of virology \n                           86, 6970\u20136978 (2012).","journal-title":"Journal of virology"},{"key":"8326_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2016.01.016","volume":"16","author":"EJ Grant","year":"2016","unstructured":"Grant, E. J., Quinones-Parra, S. M., Clemens, E. B. & Kedzierska, K. Human influenza viruses and CD8(+) T cell responses. Curr Opin Virol \n                           16, 132\u2013142 (2016).","journal-title":"Curr Opin Virol"},{"key":"8326_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/jir.2009.0084","volume":"30","author":"ID Weiss","year":"2010","unstructured":"Weiss, I. D. et al. IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interferon Cytokine Res \n                           30, 439\u2013449 (2010).","journal-title":"J Interferon Cytokine Res"},{"key":"8326_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-3083.1978.tb00536.x","volume":"8","author":"KL Yap","year":"1978","unstructured":"Yap, K. L. & Ada, G. L. The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen. Scand J Immunol \n                           8, 413\u2013420 (1978).","journal-title":"Scand J Immunol"},{"key":"8326_CR24","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1128\/JVI.00365-12","volume":"86","author":"K Shinya","year":"2012","unstructured":"Shinya, K. et al. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. Journal of virology \n                           86, 6055\u20136066 (2012).","journal-title":"Journal of virology"},{"key":"8326_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","volume":"9","author":"LE Markowitz","year":"1990","unstructured":"Markowitz, L. E., Preblud, S. R., Fine, P. E. & Orenstein, W. A. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J \n                           9, 101\u2013110 (1990).","journal-title":"Pediatr Infect Dis J"},{"key":"8326_CR26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med \n                           357, 1903\u20131915 (2007).","journal-title":"N Engl J Med"},{"key":"8326_CR27","first-page":"151","volume":"330","author":"D Naniche","year":"2009","unstructured":"Naniche, D. Human immunology of measles virus infection. Curr Top Microbiol Immunol \n                           330, 151\u2013171 (2009).","journal-title":"Curr Top Microbiol Immunol"},{"key":"8326_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00006454-199503000-00007","volume":"14","author":"B Samb","year":"1995","unstructured":"Samb, B. et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J \n                           14, 203\u2013209 (1995).","journal-title":"Pediatr Infect Dis J"},{"key":"8326_CR29","doi-asserted-by":"publisher","first-page":"e44447","DOI":"10.1371\/journal.pone.0044447","volume":"7","author":"LA Cornelissen","year":"2012","unstructured":"Cornelissen, L. A. et al. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice. PLoS One \n                           7, e44447 (2012).","journal-title":"PLoS One"},{"key":"8326_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/JVI.01514-06","volume":"81","author":"J Ge","year":"2007","unstructured":"Ge, J. et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of virology \n                           81, 150\u2013158 (2007).","journal-title":"Journal of virology"},{"key":"8326_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/JVI.02321-12","volume":"87","author":"Z Li","year":"2013","unstructured":"Li, Z. et al. Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge. Journal of virology \n                           87, 354\u2013362 (2013).","journal-title":"Journal of virology"},{"key":"8326_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11262-010-0530-3","volume":"41","author":"M Okamatsu","year":"2010","unstructured":"Okamatsu, M. et al. Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes \n                           41, 351\u2013357 (2010).","journal-title":"Virus Genes"},{"key":"8326_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.antiviral.2008.08.006","volume":"80","author":"Y Terao-Muto","year":"2008","unstructured":"Terao-Muto, Y. et al. Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines. Antiviral research \n                           80, 370\u2013376 (2008).","journal-title":"Antiviral research"},{"key":"8326_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cimid.2006.03.004","volume":"29","author":"M Masuda","year":"2006","unstructured":"Masuda, M. et al. Characterization of monoclonal antibodies directed against the canine distemper virus nucleocapsid protein. Comparative immunology, microbiology and infectious diseases \n                           29, 157\u2013165 (2006).","journal-title":"Comparative immunology, microbiology and infectious diseases"},{"key":"8326_CR35","first-page":"93","volume":"55","author":"K Soda","year":"2008","unstructured":"Soda, K. et al. Development of vaccine strains of H5 and H7 influenza viruses. The Japanese journal of veterinary research \n                           55, 93\u201398 (2008).","journal-title":"The Japanese journal of veterinary research"},{"key":"8326_CR36","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/pmic.200701051","volume":"8","author":"K Hagiwara","year":"2008","unstructured":"Hagiwara, K. et al. Phosphorylation of measles virus nucleoprotein upregulates the transcriptional activity of minigenomic RNA. Proteomics \n                           8, 1871\u20131879 (2008).","journal-title":"Proteomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08326-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:07:29Z","timestamp":1671793649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08326-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8326"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08326-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]},"assertion":[{"value":"27 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12017"}}